Constarium
← Search

Data · dataset · 2026

Congress Presentation: IMS 2026 Efficacy of elinzanetant in postmenopausal women with cardiometabolic comorbidities: a pooled analysis of Phase III OASIS-1 and -2 trials

Listed in ZivaHub and Deakin Research Online and DMU Figshare — shown once because both records carry DOI 10.71943/bayer.figshare.33995502.v1

<p dir="ltr">In a subset of participants with CV or metabolic comorbidities at baseline, elinzanetant rapidly reduced VMS and improved sleep disturbances and menopause-related quality of life with sustained effect.

Description

Results are broadly consistent with the results of the overall population and support the use of elinzanetant in women with CV or metabolic comorbidities.</p>

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 3 source records, 7 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3399550210 d agoJSON v1
Deakin Research Onlineoai:figshare.com:article/3399550210 d agoJSON v1
DMU Figshareoai:figshare.com:article/3399550210 d agoJSON v1
FieldAssertionExtractorEvidence
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · figshare dmu ac ukconnector:figshare_dmu_ac_uk@1.0.0
concepts[field].local:field:earth-environmentalmapping · dro deakin edu auconnector:dro_deakin_edu_au@1.0.0
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
license_textsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title